Bionano Genomics
BNGO
10 hedge funds and large institutions have $3.3M invested in Bionano Genomics in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% less ownership
Funds ownership: 0.03% → 0.03% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
42% less capital invested
Capital invested by funds: $5.71M → $3.3M (-$2.41M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$18.4K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$63.3K |
| 2 |
Millennium Management
New York
|
-$14.3K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.04K |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $2.69M | -$63.3K | -31 | -1% |
|
|
WVP
2
Worth Venture Partners
Fort Lee,
New Jersey
| $215K | – | – | – |
|
|
MIM
3
Monashee Investment Management
Boston,
Massachusetts
| $202K | – | – | – |
|
|
4
Millennium Management
New York
| $102K | -$14.3K | -7 | -9% |
|
5
Federated Hermes
Pittsburgh,
Pennsylvania
| $41K | – | – | – |
|
6
Victory Capital Management
San Antonio,
Texas
| $20K | – | – | – |
|
|
7
BlackRock
New York
| $15K | +$18.4K | +9 | +900% |
|
|
PAM
8
Panagora Asset Management
Boston,
Massachusetts
| $11K | -$2.04K | -1 | -13% |
|
9
Morgan Stanley
New York
| $1K | – | – | – |
|
10
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| $1K | +$2.04K | +1 | New |
|
|
12
Nordea Investment Management
Stockholm,
Sweden
| – | -$2K | -1 | Closed |
|
BNGO Hedge Fund Activity: Q2 2019 in Review
10 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2019, worth a combined $3.3M — down 42% from $5.71M a quarter earlier.
Fund positioning in BNGO was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $18.4K. The largest seller was Sio Capital Management, cutting an estimated $63.3K.
- 10 institutional investors held Bionano Genomics (BNGO) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $3.3M of Bionano Genomics stock for Q2 2019, down 42% quarter-over-quarter.
- 1 fund opened new Bionano Genomics positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest Bionano Genomics buyer in Q2 2019 was BlackRock, an estimated $18.4K added.
- The largest Bionano Genomics seller in Q2 2019 was Sio Capital Management, an estimated $63.3K sold.
Based on aggregated 13F filings for Q2 2019.